The outlook of companies tied to Sildenafil's past presents a challenging investment scenario . While the initial surge generated substantial returns , generic copies have significantly diminished sales . https://adult095234.blogmazing.com/40571799/the-copyright-and-big-pharma-a-risky-opportunity